Mounting diagnostics backlogs were already stretching overburdened NHS pathology teams. Then COVID-19 hit.
Cutting-edge lab automation technologies can relieve this pressure by eliminating repetitive tasks. In this whitepaper, we explore how NHS pathology directors can use automation solutions to scale testing and tackle the growing strain on diagnostics in the coming years.
“The Covid-19 pandemic has exacerbated the pre-existing problems in Diagnostics”
Can lab automation relieve the pressure on diagnostics teams?
Conducting testing at the scale needed to tackle the COVID-19 pandemic has meant that thousands of (highly-trained) lab workers are conducting exhausting, repetitive tasks over and over again. And it’s exposed a huge problem in diagnostics: Manual testing leads to targets missed, human error and risks to staff’s safety.
Lab automation removes all these problems, tripling the output of test and trace facilities and ensuring social distancing is possible for key workers.
But for a lab automation solution to be effective, there are a few key requirements:
🤖 Accelerating the output
🤖 Rapid deployment
🤖 Flexibility and integration with existing equipment
At Automata, we worked with one national test and trace facility to create a lab automation solution that could automate the reformatting COVID-19 samples, while meeting all these requirements.
With the Autosampler solution, we were able to clinically validate and scale testing from 1,000 a day with manual testing, to 100,000 a day with automation. The lab was also able to reduce costs by 84%.
Get the whitepaper to learn how pathology leaders can be empowered to run simple, hassle-free automation on-site – and how one national test and trace facility scaled their COVID-19 testing with automation on-site in a matter of weeks.